Priyadarsinee L

ORCID: 0009-0002-1527-8470 · 2 papers in corpus
other 2023
PloS one ·doi:10.1371/journal.pone.0289890

Drug repurposing has emerged as an important strategy and it has a great potential in identifying therapeutic applications for COVID-19. An extensive virtual screening of 4193 FDA approved drugs has been carried out against 24 proteins of S…

2022
·doi:10.21203/rs.3.rs-2083023/v1

AbstractDrug repurposing is emerging as a vital approach for identifying known drugs with potential therapeutic indications for COVID-19 disease. This aims to categorize and develop therapeutics by identifying existing approved drugs from d…